Abstract
In low- and middle-income countries (LMICs), enteric infections pose a significant threat to children’s health. However, understanding the specifics of when, where, and how young children in LMICs are exposed to enteric pathogens and the roles of animal reservoirs, environmental media, and human hosts play during exposure remains limited. This study systematically evaluates infants’ exposure to E. coli through various pathways in the rural Haramaya woreda of Ethiopia. Between June 2021 and June 2022, we conducted over 1300 hours of structured behavioral observations on 79 infants when aged 4–8 months (Timepoint 1) and 11–15 months (Timepoint 2). Enumerators recorded the infant’s behavior related to exposure, including when and where it occurred, using the Countee © application. Concurrently, we collected 1338 environmental samples from key contact interfaces between infants, other people, and the environment to test for E. coli. We used a competing hazard model for duration-based behaviors, an inhomogeneous Poisson point process model for frequency-based behaviors, and a left-censored lognormal distribution model for E. coli contamination levels. The behavioral and environmental information was then integrated into an agent-based exposure model framework to quantify the exposure to E. coli through different pathways.
The infant behavior, which altered the relative importance of different exposure pathways, changed as children grew older. Notably, we observed increased rates of touching behavior (e.g., touching fomites) and soil-pica, increased consumption of solid food, and more time spent on the bare ground at Timepoint 2. The major sources of exposure to E. coli were food and breastfeeding at Timepoint 1 and food and soil at Timepoint 2. This study provides insights for interventions to minimize infants’ risk of exposure to fecal contamination and subsequent risk of enteric infections, including improved food handling practices, enhanced personal hygiene for breastfeeding caregivers, and education on the risk of soil-pica.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was supported by the Bill and Melinda Gates Foundation (INV-007705).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the University of Florida Institutional Review Board (IRB201802987), the Institutional Health Research Ethics Review Committee (IHREC), Haramaya University, Ethiopia (IHRERC/091/2020), and National Research Ethics Review Committee, Ministry of Science and Higher Education (MoSHE), Ethiopia (SBA\117\7103\20). Written informed consent was obtained from all participants of the study in the local language (Afan Oromo).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Declaration of Competing Interest The authors declare that they have no conflicts of interest.
Data Availability
The data utilized in this study are available upon reasonable request. The dataset includes high-resolution behavioral and microbiological sampling data collected as part of the EXCAM project. This data has been anonymized to protect the privacy of the participants. Access to the data will be granted to qualified researchers to replicate the findings or conduct further research, subject to approval by the Institutional Review Board and data use agreements to ensure ethical handling and use of the data. Researchers interested in accessing the dataset should contact the Principal Investigator, Dr. Song Liang at songliang{at}umass.edu. Detailed metadata and documentation are available to support the understanding and use of the dataset.
